Background: The achromic macules and patches seen in vitiligo, which is a multifactorial condition, are caused by a decrease in skin pigmentation. In order to halt the advancement and stimulate skin repigmentation, there are presently a number of medicinal treatments that can be used. The pigmentation effects of these treatments, whether used alone or in combination, have been varied, but generally speaking, they have been safe and successful. There is currently no cure for vitiligo, and no treatment has been shown to reliably restore pigmentation in most patients. Depending on geographic location, clinical presentation, and the existence of disease activity, personalized treatment plans are most effective. We intended to provide an outline of different updated lines of treatment for vitiligo because it is a tough condition and because management regimens may differ for patients of different races and skin colors.

Conclusion: A number of variables influence the therapeutic approach selection process, including vitiligo distribution, type, patient age, as well as skin phototype. Researchers have found that vitiligo sufferers are more likely to suffer from depression, and the condition itself can have a major impact on their daily lives. Immunosuppressants, including topical and oral, phototherapy, and surgical procedures are common methods of management. Conventional medicine, on the other hand, has a poor response rate, frequent side effects, and a high recurrence rate.